Ballester, Tirona, and Ballester have written an admirably thorough review of hematopoietic stem cell transplantation in the elderly, and current results provide optimism for tolerability and efficacy. It is clear that new advances must be explored, developed, and studied in clinical trials involving older adults with cancer. As the population ages, representation of older patients in clinical trials must be increased to translate findings into meaningful applications of HSCT in this challenging group of patients.
|Original language||English (US)|
|State||Published - Nov 1 2007|
ASJC Scopus subject areas
- Cancer Research